Medindia

X

Quark Pharmaceuticals Announces Nature Medicine Publication for Role of RTP801 in Pulmonary Injury and Emphysema

Monday, May 17, 2010 General News J E 4
Advertisement

Quark Pharmaceuticals, Inc.

Juliana Friedman

+972 89 30 5111

jfriedman@quarkpharma.com

The Ruth Group (investors / media)

Sara Pellegrino / Jason Rando

(646) 536-7002 / 7025

spellegrino@theruthgroup.com

jrando@theruthgroup.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
ADMIRE-HF Clinical Trial Published in the Journal ...
S
Gloria Gaynor to Perform at Jacksonville's Senior ...